Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Liver Histology01:27

Liver Histology

The microscopic anatomy of the liver is a complex and intricate system that comprises numerous structural units known as liver lobules, each of which is comparable in size to a sesame seed. These hexagonal structures consist of plates of liver cells or hepatocytes, which are characterized by their versatility and abundance of cellular apparatus like rough and smooth ER, Golgi apparatus, peroxisomes, and mitochondria.
Hepatocytes perform a variety of essential functions. They secrete...
Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Morphometric Quantification of Steatosis and Fibrosis in Metabolic Liver Disease Associated With Type 2 Diabetes.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2025
Same author

Decision Tree for the Performance of Intraoperative Liver Biopsy During Bariatric Surgery.

Obesity surgery·2021
Same author

Diagnostic of hepatic fibrosis with the XL probe of the Fibroscan versus biopsies in patients candidates to bariatric surgery.

Clinical nutrition ESPEN·2020
Same author

Impact of controlled attenuation parameter on detecting fibrosis using liver stiffness measurement.

Alimentary pharmacology & therapeutics·2018
Same author

Reply to Wang and Kan.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2018
Same author

Cholangiopathy in critically ill patients surviving beyond the intensive care period: a multicentre survey in liver units.

Alimentary pharmacology & therapeutics·2017
Same journal

[Not Available].

Gastroenterologie clinique et biologique·2014
Same journal

[Not Available].

Gastroenterologie clinique et biologique·2014
Same journal

[Not Available].

Gastroenterologie clinique et biologique·2014
Same journal

[Not Available].

Gastroenterologie clinique et biologique·2014
Same journal

[Not Available].

Gastroenterologie clinique et biologique·2014
Same journal

[Not Available].

Gastroenterologie clinique et biologique·2014
See all related articles

Related Experiment Video

Updated: Jun 28, 2026

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy
07:10

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy

Published on: June 18, 2020

Liver biopsy.

P Bedossa1

  • 1Department of Pathology, Beaujon Hospital, Clichy, University Denis Diderot - Paris 7, France. pierre.bedossa@bjn.aphp.fr

Gastroenterologie Clinique Et Biologique
|December 17, 2008
PubMed
Summary
This summary is machine-generated.

Liver biopsy remains the gold standard for assessing liver fibrosis, a key indicator of chronic liver disease progression. Despite limitations, careful biopsy techniques ensure accurate staging and inform treatment strategies for long-term patient management.

More Related Videos

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis (NASH) Resolution
04:14

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis (NASH) Resolution

Published on: April 16, 2019

Mapping Hepatic Stellate Cell Morphology in Mouse Models of Liver Fibrosis
06:55

Mapping Hepatic Stellate Cell Morphology in Mouse Models of Liver Fibrosis

Published on: February 13, 2026

Related Experiment Videos

Last Updated: Jun 28, 2026

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy
07:10

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy

Published on: June 18, 2020

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis (NASH) Resolution
04:14

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis (NASH) Resolution

Published on: April 16, 2019

Mapping Hepatic Stellate Cell Morphology in Mouse Models of Liver Fibrosis
06:55

Mapping Hepatic Stellate Cell Morphology in Mouse Models of Liver Fibrosis

Published on: February 13, 2026

Area of Science:

  • Hepatology
  • Pathology
  • Gastroenterology

Background:

  • Liver fibrosis involves excessive extracellular matrix deposition, causing anatomical damage.
  • Accurate assessment is crucial for managing chronic liver disease.
  • Liver biopsy is the current gold standard for direct fibrosis evaluation.

Purpose of the Study:

  • To highlight the importance of liver biopsy in assessing liver fibrosis.
  • To discuss the role of biopsy in establishing diagnostic algorithms.
  • To emphasize biopsy's value in patient follow-up and treatment planning.

Main Methods:

  • Liver biopsy as the primary diagnostic tool.
  • Acknowledging biopsy's limitations and mitigation strategies.
  • Utilizing biopsy data to develop biological test combinations.

Main Results:

  • Biopsy provides direct assessment of liver fibrosis extent.
  • Appropriate precautions minimize biopsy-related inaccuracies.
  • Biopsy offers comprehensive information beyond fibrosis staging.

Conclusions:

  • Liver biopsy is essential for accurate staging of liver fibrosis.
  • It serves as the benchmark for developing non-invasive diagnostic markers.
  • Biopsy findings guide clinical decisions in chronic liver disease management.